College of Engineering researchers develop technology to increase production of biologic pharmaceuticals for diabetes treatment
Chemical and Life Science Engineering Professor Michael “Pete” Peters, Ph.D., is investigating more efficient ways to manufacture biologic pharmaceuticals using a radial flow bioreactor he developed.
Disabling COVID’s ‘key’
As COVID-19 mutates to become more contagious, Michael Peters, Ph.D., is accelerating efforts to disable the “spikes” that give the coronavirus particle its familiar shape — and its power to prey on cells.
Michael H. Peters, Ph.D., discusses COVID-19 variants
Sharon Bowes, anchor and producer of NewsPoint360, interviews Michael H. Peters, Ph.D., professor in the Department of Chemical and Life Science Engineering at VCU Engineering.
Understanding variants of the coronavirus can offer clues about the next threats
Scientists are closely watching the emergence of variants of the coronavirus that may be more infectious. The spread of troubling variants in different parts of the world, including in the U.S., is happening as officials are racing to inject vaccines into the arms of adult populations.
VCU researcher developing potential treatment to block COVID-19
Michael H. Peters, Ph.D., professor in the Virginia Commonwealth University’s Department of Chemical and Life Science Engineering, is developing a potential COVID-19 treatment for Hoth Therapeutics Inc., a biopharmaceutical company based in New York, N.Y.
VCU Engineering faculty win COVID-19 research funding
Several VCU College of Engineering researchers were selected to receive the first round of awards from the VCU COVID-19 Rapid Research Funding Opportunity.
VCU researcher harnessing supercomputers in the race against COVID-19
Michael H. Peters, Ph.D., professor in the Department of Chemical and Life Science Engineering, is using powerful supercomputers at NASA’s Ames Research Center in California’s Silicon Valley to investigate the “spike” protein of the novel coronavirus that causes COVID-19.
